Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis

por Stipancic, Kaila L., Yunusova, Yana, Campbell, Thomas F., Wang, Jun, Berry, James D., Green, Jordan R.
Publicado 2021

Assessing Oromotor Capacity in ALS: The Effect of a Fixed-Target Task on Lip Biomechanics

por Eshghi, Marziye, Stipancic, Kaila L., Mefferd, Antje, Rong, Panying, Berry, James D., Yunusova, Yana, Green, Jordan R.
Publicado 2019

Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis

por Brooks, Benjamin Rix, Berry, James D., Ciepielewska, Malgorzata, Liu, Ying, Zambrano, Gustavo Suarez, Zhang, Jeffrey, Hagan, Melissa
Publicado 2022

FUS is sequestered in nuclear aggregates in ALS patient fibroblasts

por Schwartz, Jacob C., Podell, Elaine R., Han, Steve S. W., Berry, James D., Eggan, Kevin C., Cech, Thomas R.
Publicado 2014

Bulbar and speech motor assessment in ALS: Challenges and future directions

por Green, Jordan R., Yunusova, Yana, Kuruvilla, Mili S., Wang, Jun, Pattee, Gary L., Synhorst, Lori, Zinman, Lorne, Berry, James D.
Publicado 2013

Preclinical rodent toxicity studies for long term use of ceftriaxone

por Ratti, Elena, Berry, James D., Greenblatt, David J., Loci, Lorena, Ellrodt, Amy Swartz, Shefner, Jeremy M., Cudkowicz, Merit E.
Publicado 2015

Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems

por Rong, Panying, Yunusova, Yana, Wang, Jun, Zinman, Lorne, Pattee, Gary L., Berry, James D., Perry, Bridget, Green, Jordan R.
Publicado 2016

Developing multidisciplinary clinics for neuromuscular care and research

por Paganoni, Sabrina, Nicholson, Katie, Leigh, Fawn, Swoboda, Kathryn, Chad, David, Drake, Kristin, Haley, Kellen, Cudkowicz, Merit, Berry, James D.
Publicado 2017

Improved stratification of ALS clinical trials using predicted survival

por Berry, James D., Taylor, Albert A., Beaulieu, Danielle, Meng, Lisa, Bian, Amy, Andrews, Jinsy, Keymer, Mike, Ennist, David L., Ravina, Bernard
Publicado 2018

Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study

por Thonhoff, Jason R., Beers, David R., Zhao, Weihua, Pleitez, Milvia, Simpson, Ericka P., Berry, James D., Cudkowicz, Merit E., Appel, Stanley H.
Publicado 2018

Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry’s Research Notification M...

por Mehta, Paul, Raymond, Jaime, Han, Moon Kwon, Larson, Theodore, Berry, James D, Paganoni, Sabrina, Mitsumoto, Hiroshi, Bedlack, Richard Stanley, Horton, D Kevin
Publicado 2021

Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study

por Yunusova, Yana, Waito, Ashley, Barnett, Carolina, Huynh, Anna, Martino, Rosemary, Abrahao, Agessandro, Pattee, Gary L, Berry, James D, Zinman, Lorne, Green, Jordan R
Publicado 2022

Longitudinal comparison of the self‐entry Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised (ALSFRS‐RSE) and Rasch‐Built Overall Amyotrophic Lateral Sclerosis Disabilit...

por Johnson, Stephen A., Burke, Katherine M., Scheier, Zoe A., Keegan, Mackenzie A., Clark, Alison P., Chan, James, Fournier, Christina N., Berry, James D.
Publicado 2022

Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

por Genge, Angela, van den Berg, Leonard H., Frick, Glen, Han, Steve, Abikoff, Cori, Simmons, Adam, Lin, Qun, Patra, Kaushik, Kupperman, Erik, Berry, James D.
Publicado 2023

Face and content validation of the amyotrophic lateral sclerosis—Bulbar dysfunction index (ALS-BDI)

por Yunusova, Yana, Waito, Ashley, Barnett Tapia, Carolina, Huynh, Anna, Martino, Rosemary, Abrahao, Agessandro, Pattee, Gary L., Berry, James D., Zinman, Lorne, Green, Jordan R.
Publicado 2023

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis

por Green, Jordan R., Allison, Kristen M., Cordella, Claire, Richburg, Brian D., Pattee, Gary L., Berry, James D., Macklin, Eric A., Pioro, Erik P., Smith, Richard A.
Publicado 2018

Design and results of a smartphone‐based digital phenotyping study to quantify ALS progression

por Berry, James D., Paganoni, Sabrina, Carlson, Kenzie, Burke, Katherine, Weber, Harli, Staples, Patrick, Salinas, Joel, Chan, James, Green, Jordan R., Connaghan, Kathryn, Barback, Josh, Onnela, Jukka Pekka
Publicado 2019

Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures

por Johnson, Stephen A., Karas, Marta, Burke, Katherine M., Straczkiewicz, Marcin, Scheier, Zoe A., Clark, Alison P., Iwasaki, Satoshi, Lahav, Amir, Iyer, Amrita S., Onnela, Jukka-Pekka, Berry, James D.
Publicado 2023

Smartphone data during the COVID‐19 pandemic can quantify behavioral changes in people with ALS

por Beukenhorst, Anna L., Collins, Ella, Burke, Katherine M., Rahman, Syed Minhajur, Clapp, Margaret, Konanki, Sai Charan, Paganoni, Sabrina, Miller, Timothy M., Chan, James, Onnela, Jukka‐Pekka, Berry, James D.
Publicado 2020

Rate of speech decline in individuals with amyotrophic lateral sclerosis

por Eshghi, Marziye, Yunusova, Yana, Connaghan, Kathryn P., Perry, Bridget J., Maffei, Marc F., Berry, James D., Zinman, Lorne, Kalra, Sanjay, Korngut, Lawrence, Genge, Angela, Dionne, Annie, Green, Jordan R.
Publicado 2022